Nerviano, Italy_June_19_Accelera Srl (Accelera), a global leader in contract research and development services and a member of the NMS Group, is pleased to announce the nomination of Luca Leone as the new Chief Executive Officer (CEO) of the organization, effective immediately. The appointment of Luca comes at an exciting time for Accelera, as it continues to expand its services and drive innovation in the contract research organization (CRO) industry.

With an impressive track record in the CRO, Contract Development and Manufacturing (CDMO) and biotechnology sectors, Luca brings a wealth of knowledge and experience to Accelera. With expertise spanning over two decades, Luca has consistently demonstrated exceptional leadership and a deep understanding of the evolving needs of these industries that are tightly related to each other. This makes Luca the ideal candidate to lead Accelera into its next phase of growth and success.

As the newly appointed CEO, Luca will spearhead Accelera’s strategic direction, aiming to further fortify its leading tox practices and strengthen its position as a trusted partner for pharmaceutical and biotechnology companies worldwide, leveraging on his strong track record of development and execution of strategic initiatives that resulted in significant business expansion and increased market presence. Luca’s visionary leadership, combined with his ability to drive innovation and foster a culture of excellence, will undoubtedly play a crucial role in driving Accelera’s growth trajectory.

“We are thrilled to nominate Luca as the CEO of Accelera. His proven expertise, strategic acumen, and deep industry knowledge make him the perfect fit for this role,” said Hugues Dolgos, Pharm.D., CEO of the NMS Group and Chairman of Accelera. “We are confident that Luca will bring fresh perspectives and guide Accelera towards new heights, capitalizing on the immense opportunities in the CRO space.“

“I am excited to arrive at the time when Accelera just received its full accreditation from AAALAC. This demonstrates further that Accelera is managed by such a robust and diligent leadership team. I humbled to work alongside with the team and our clients to advance the discovery and development of all the life-changing therapies. We will continue to innovate Accelera and provide comprehensive solutions that accelerate the delivery of breakthrough treatments to patients in need.” Luca commented.

Link:20230619-Accelera appoint Luca Leone as CEO

from NMSGroup